Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trial.
Richard KazibweMatthew SingletonMichael P BancksJuliana NamutebiAziz HammouMichael ShapiroJoseph YeboahPublished in: Diabetes, obesity & metabolism (2024)
In high-risk individuals with type 2 diabetes, the use of aspirin for primary prevention was not associated with a decreased risk of incident CVD or all-cause mortality.